Fig. 3From: Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cellsTKIs inhibit ABC transporters. Both TKIs and ABC transporters compose of ATP-binding site. TKIs connect to ATP-binding site of ABC transporters and inhibit its function of discharging anticancer drugs out of MDR cellsBack to article page